# Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease

> **NCT00345774** · PHASE2 · COMPLETED · sponsor: **Epix Pharmaceuticals, Inc.** · enrollment: 72 (estimated)

## Conditions studied

- Pulmonary Hypertension
- Chronic Obstructive Pulmonary Disease

## Interventions

- **DRUG:** PRX-08066

## Key facts

- **NCT ID:** NCT00345774
- **Lead sponsor:** Epix Pharmaceuticals, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** —
- **Final completion:** 2007-06
- **Target enrollment:** 72 (ESTIMATED)
- **Last updated:** 2008-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00345774

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00345774, "Safety and Effectiveness of PRX-08066 in Patients With Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00345774. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*